| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.009 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.009 |